ZBIO
Zenas Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$24.04
-0.46 ▼ -1.88%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$24.04
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -4.53 | Insider Own | 56.05% | Shs Outstand | 0.04B | Perf Week | -4.91% |
| Market Cap | 1.29B | Forward P/E | - | EPS next Y | 12.24% | Insider Trans | 4.1% | Shs Float | 0.02B | Perf Month | 3.31% |
| Enterprise Value | 1.00B | PEG | - | EPS next Q | -1.63 | Inst Own | 45.73% | Short Float | 34.01% | Perf Quarter | -38.52% |
| Income | -0.19B | P/S | 86.03 | EPS this Y | 1.57% | Inst Trans | 12.64% | Short Ratio | 9.42 | Perf Half Y | 19.19% |
| Sales | 0.01B | P/B | 5.17 | EPS next 5Y | 9.25% | ROA | -52.35% | Short Interest | 8.02M | Perf YTD | -33.79% |
| Book/sh | 4.65 | P/C | 4.44 | EPS past 3/5Y | -9.85% - | ROE | -68.33% | 52W High | -46.1% ($44.60) | Perf Year | 175.37% |
| Cash/sh | 5.42 | P/FCF | - | Sales past 3/5Y | - | ROIC | -96.59% | 52W Low | 293.45% ($6.11) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -38.04% | Gross Margin | 99.47% | Volatility(W/M) | 7.13% 7.55% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 66.69 | Sales Y/Y TTM | -70% | Oper. Margin | -1304.64% | ATR (14) | 1.9 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.66 | EPS Q/Q | -32.2% | Profit Margin | -1265.99% | RSI (14) | 44.51 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.66 | Sales Q/Q | - | SMA20 | -6.96% ($25.84) | Beta | -1.39 | Target Price | $40.75 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/02/25 | SMA50 | 4.69% ($22.96) | Rel Volume | 0.58 | Prev Close | $24.5 |
| Employees | 130 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -7.18% -53.62% | SMA200 | 7.04% ($22.46) | Avg Volume(3M) | 0.85M | Price | $24.04 |
| IPO | 2024/9/13 | Option/Short | Yes/Yes | Trades | 6657 | Volume | 491,524 | Change | -1.88% |
뉴스 로딩 중...